Bunge Limited to Hold Extraordinary General Meeting of Shareholders - Seite 2

Website Information

We routinely post important information for investors on our website, www.bunge.com, in the "Investor Center" section. We may use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investors section of our website, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains certain forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995, including those relating to the EGM and the Redomestication and the Acquisition. You can identify these statements by the use of the words “may,” “will,” “could,” “should,” “would,” “plans,” “expects,” “anticipates,” “continue,” “estimate,” “project,” “intend,” “likely,” “forecast,” “probable,” “potential,” and similar expressions. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. Such risks and uncertainties include, but are not limited to: (1) the inability to consummate the Redomestication or the Acquisition within the anticipated time period, or at all, due to any reason, including the failure to obtain the necessary shareholder or regulatory approvals or the failure to satisfy the other conditions to the consummation of the Acquisition; (2) the risk that the Business Combination Agreement may be terminated, and, in certain circumstances, require Bunge to pay a termination fee; (3) the risk that the Redomestication or the Acquisition disrupt Bunge’s current business and financing plans and operations or diverts management’s attention from its ongoing business; (4) the effect of the announcement of the Redomestication or the Acquisition on Bunge’s ability to retain and hire key personnel and maintain relationships with its customers, suppliers and others with whom it does business; (5) the effect of the announcement of the Redomestication or the Acquisition on Bunge’s operating results and business generally; (6) the amount of costs, fees and expenses related to the Redomestication and the Acquisition; (7) the risk that Bunge’s stock price may decline significantly if either of the Redomestication or the Acquisition are not consummated; (8) the nature, cost and outcome of any litigation and other legal proceedings, including any such proceedings related to the Redomestication or the Acquisition and instituted against Bunge and others; (9) among other factors that could affect Bunge’s business such as, without limitations, the effects of weather conditions and the impact of crop and animal disease on Bunge’s business, the impact of global and regional economic, agricultural, financial and commodities market, political, social and health conditions, changes in government policies and laws affecting Bunge’s business, including agricultural and trade policies, financial markets regulation and environmental, tax and biofuels regulation, the impact of industry conditions, including fluctuations in supply, demand and prices for agricultural commodities and other raw materials and products that Bunge sells and uses in its business, fluctuations in energy and freight costs and competitive developments in its industries, and operational risks, including industrial accidents, natural disasters, pandemics or epidemics and cybersecurity incidents; and (10) other risks to consummation of the proposed Redomestication and Acquisition, including the risk that either or both of the proposed Redomestication or Acquisition will not be consummated within the expected time period or at all.